SearchSearch results for: “”

Stibbe advised Blackstone on the sale of the Sheraton Amsterdam Airport Hotel and Conference Center to InterGlobe.

Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.

On 21 February 2018, the Administrative Jurisdiction Department of the Council of State rendered its judgment on the construction of the Drentse Monden and Oostermoer wind farm. The zoning plan and other permits are now irrevocable and the construction of

On 11 July 2018, the Administrative Jurisdiction Division of the Council of State rendered its judgment on, among other things, the zoning plan, the environmental permit and the Nature Conservation Act permit for the Fryslân wind farm. The objections to t

On 4 July 2018, the Administrative Jurisdiction Department of the Council of State rendered its judgment on the permitting for wind farm Oostpolder.

Stibbe advises Elementis, a UK listed global specialty chemicals company, on the acquisition of Mondo Minerals Holdings B.V. for an enterprise value of $600 million on a cash and debt free basis.

Stibbe advises an online housing company on matters concerning public law regulation.

Stibbe advises a gaming and entertainment company with regard to several casinos in different municipalities on whether municipal exploitation permits should be tendered and if so, under what conditions.

Stibbe acted as counsel to Iret Develoment in its tendering procedure, development, and negotiations of the more than EUR 100 million public–private partnership (PPP) project, which is the new police headquarters building in Antwerp.

Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).

Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. 

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.